Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Safety of Anti-PD-L1 Inhibition in HIV-1-Infected Patients With Cancer-Reply.
Novel Approaches Towards a Functional Cure of HIV/AIDS.
Galectin-8 in the onset of the immune response and inflammation.
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.
Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
Impact of HIV infection on aging and immune status.
-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants.
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.